The Society for Innovation and Entrepreneurship (SINE) at Indian Institute of Technology Bombay (IIT-B) recently completed its 15 years and announced that any startup across the country can have access to its integrated prototype laboratory.
Talking about the same, Chief Executive Officer of SINE, Poyni Bhatt stated that this facility provides basic prototyping tools for entrepreneurs. Startups can use the facility for mechanical, biotechnological and electronic prototyping.
Also Read: IIT-B's TechFest Team Brings World’s First Actor-Performer Humanoid 'RoboThespian' To India
The charges will be nominal and will mostly be on a pay-per-use model as the laboratory has to be sustained. Startups from IIT-Bombay can also make use of this facility. Taking into note the lack of access to a state-of-the-art lab to build prototypes, SINE has come up with this initiative.
Moreover, as part of new research, scientists from IIT-Bombay have collectively built a technology that utilizes the patient’s immune system to fight cancer. Also known as immunotherapy, the technology can cost close to ₹4-5 crores, but researchers believe that if a technology like this is developed within India, it can be made available to cancer patients for ₹15 lakh.
Further, it is said that this treatment will be less painful than chemotherapy, surgery, or radiation, while experts add that the chances of a relapse are also quite low with this method.
This treatment is proven to be particularly effective against leukaemia. However, it is yet to become mainstream in India, which may take a while yet. But as the scientists rightly point out, if this method brings out success even in a small margin of patients, it will bring about a massive change in treating cancer in the country.
Also Read: IIT Bombay, TISS Students Protest Against Police Brutality In JMI, AMU
Share
Tweet
